UroGen Pharma Ltd.

General ticker "URGN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $630.6M (TTM average)

UroGen Pharma Ltd. follows the US Stock Market performance with the rate: 50.3%.

Estimated limits based on current volatility of 5.3%: low 18.40$, high 20.47$

Factors to consider:

  • Earnings expected soon, date: 2026-03-09 bmo
  • Total employees count: 235 as of 2024
  • Top business risk factors: Regulatory and compliance, Product liability, Manufacturing and commercialization risks, Cybersecurity threats, Operational and conduct risks
  • Current price 58.3% above estimated high
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [5.83$, 14.52$]
  • 2025-12-31 to 2026-12-31 estimated range: [4.90$, 12.39$]

Financial Metrics affecting the URGN estimates:

  • Negative: with PPE of -3.3 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -20.90 <= 0.01
  • Positive: Interest expense per share per price, % of 2.70 <= 3.28
  • Negative: negative Net income

Similar symbols

Short-term URGN quotes

Long-term URGN plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $82.71MM $90.40MM
Operating Expenses $148.25MM $187.18MM
Operating Income $-65.54MM $-96.78MM
Non-Operating Income $-32.79MM $-27.26MM
Interest Expense $14.71MM $12.52MM
R&D Expense $45.61MM $57.15MM
Income(Loss) $-98.32MM $-124.04MM
Taxes $3.92MM $2.83MM
Profit(Loss)* $-102.24MM $-126.87MM
Stockholders Equity $-65.21MM $0.12MM
Inventory $5.67MM $9.23MM
Assets $178.31MM $285.71MM
Operating Cash Flow $-76.38MM $-96.77MM
Capital expenditure $0.19MM $0.29MM
Investing Cash Flow $-0.95MM $-20.61MM
Financing Cash Flow $116.93MM $194.62MM
Earnings Per Share** $-3.55 $-2.96

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.